1. "2005"
Formats
  1. Journal Article (1579)
  2. Meeting Abstract (692)
  3. Book Section (139)
  4. Conference Paper (22)
  5. Book Whole (10)
Groups
  1. Department of Medicine (687)
  2. Surgery (543)
  3. Sloan Kettering Institute Faculty (472)
  4. GSK Faculty (467)
  5. Solid Tumor Oncology Division (402)
  6. Survivorship Research (336)

More Groups

People
  1. Clifford Hudis (50)
  2. Howard Scher (50)
  3. David Klimstra (49)
  4. Mark Kris (44)
  5. Larry Norton (40)
  6. Murray Brennan (38)

More People

Years
  1. 2005 (2442)
Publications
  1. Journal of Clinical Oncology (234)
  2. Blood (112)
  3. Cancer Research (85)
  4. Modern Pathology (56)
  5. Clinical Cancer Research (50)
  6. International Journal of Radiation Oncology, Biology, Physics (49)

More Publications

Publishers
  1. American Society of Clinical Oncology (234)
  2. Elsevier Inc. (228)
  3. Springer (173)
  4. American Association for Cancer Research (143)
  5. Lippincott Williams & Wilkins (140)
  6. Nature Publishing Group (125)

More Publishers

Results (2442)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quality of life in survivors of childhood and adolescent acute myelogenous leukemia (AML) does not differ by treatment (bone marrow transplant (BMT) vs. chemotherapy). A report from the children's oncology group (COG)
    Meeting Abstract

    Nicholson, H. S.; Zhou, T.; Chen, Z. J.; Moran, K.; Sklar, C.; Zeltzer, L.; Neglia, J.
    Blood (2005)

    Fulltext@MSK | Save
  • Pralatrexate (10-propargyl-10-deazaaminopterin (PRX)), a novel antifolate, effects durable complete remissions (CR) in patients with a diversity of drug resistant T-cell lymphomas with minimal toxicity
    Meeting Abstract

    O'connor, O.; Hamlin, P. A.; Neylon, E.; Moskowitz, C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Cortelli, B.; Zelenetz, A. D.; Fleisher, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Uterine cancer in patients with a history of breast cancer - Do these patients always bleed?
    Meeting Abstract

    Ng, V.; Stier, E. A.; Soslow, R.; Chuai, S.; Venkatraman, E. S.; Sonoda, Y.
    Journal of Investigative Medicine (2005)

    Fulltext@MSK | Save
  • The use of urodynamics in the evaluation of the cancer patient with lower urinary tract dysfunction
    Meeting Abstract

    Newcomb, M.
    Oncology Nursing Forum (2005)

    Fulltext@MSK | Save
  • Health-related quality of life of pre-menopausal breast cancer survivors
    Meeting Abstract

    Naughton, M. J.; Petrek, J. A.; Ip, E.; Paskett, E. D.; Naftalis, E.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A comparison of the antitumour efficacy of ZD6474 and gefitinib (IresSa (TM)) in patients with NSCLC: Results of a randomized, double-blind phase II study
    Meeting Abstract

    Natale, R.; Bodkin, D.; Govindan, R.; Sleckman, B.; Rizvi, N.; Capo, A.; Germonpre, P.; Dimery, I.; Webster, A.; Ranson, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Can prostate CT contouring be improved?
    Meeting Abstract

    Narayana, V.; McLaughlin, P.; Jackson, T.; Zelefsky, M.
    Medical Physics (2005)

    Fulltext@MSK | Save
  • Stereotactic radio-surgery in the treatment of brain metastases from radioresistant tumors
    Meeting Abstract

    Narayana, A.; Patil, S.; Diamond, S.; Yamada, Y.; Gutin, P. H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • HIV-1 Nef-induced FasL induction and bystander killing is susceptible to p38 MAPK blockade
    Meeting Abstract

    Muthumani, K.; Choo, A. Y.; Hwang, D. S.; Premkumar, A.; Wadsworth, S. A.; Siekierka, J. J.; Weiner, D. B.
    FASEB Journal (2005)

    Fulltext@MSK | Save
  • Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent R00281501 by dynamic contrast enhanced MRI at 1.5T
    Meeting Abstract

    Muruganandham, M.; Lupu, M.; Dyke, J. P.; Matei, C.; Kolinsky, K.; Higgins, B.; Koutcher, J. A.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save